Journal of Medical Toxicology

, Volume 5, Issue 2, pp 59–62 | Cite as

Analysis of mushroom exposures in texas requiring hospitalization, 2005–2006

  • George A. BarbeeEmail author
  • Cristóbal S. Berry-Cabán
  • James D. Barry
  • Douglas J. Borys
  • John A. Ward
  • Steven W. Salyer
Toxicology Investigations



Texas has approximately 200 species of wild mushrooms, including toxic and hallucinogenic varieties. Mushroom ingestions in Texas were studied for 2005–2006.


Data was obtained via Texas Poison Control Centers and retrospectively reviewed. Case notes were reviewed individually regarding initial reporting, age, signs and symptoms, toxic effect, management, and patient outcomes.


A total of 742 exposures occurred during the study period. All exposures were acute and intentional. Of these exposures, 59 (7.9%) were admitted to the hospital, with 17 (28.8% of admissions) requiring admission to a critical care unit. Four cases required inpatient psychiatric admission. The average age of admitted exposures was 20.5 years, with a male-to-female predominance of 3.3:1. Eleven (22.9%) of the admitted exposures were identified, with Psilocybin being the most common agent (n = 10, 91%). Among the admissions, co-ingestions were identified with the mushroom ingestion in eleven patients (40.7%). The most common symptoms in admitted patients were vomiting (n = 34, 57.6%), nausea (n = 19, 32.2%), altered mental status (n = 17, 28.8%), abdominal pain (n = 13, 22%), and diarrhea (n = 10, 16.9%).


All mushroom exposures examined were acute and intentional. Major toxic reactions were uncommon, and no deaths were reported. Serious poisoning from mushroom ingestion is rare in Texas; however, there is greater need for information dissemination on morbidity.


mycetismus mushroom mushroom ingestion Texas Amanita 


  1. 1.
    Berger KJ, Guss DA. Mycotoxins revisited: Part I.J Emerg Med, 2005;28(1):53–62.PubMedCrossRefGoogle Scholar
  2. 2.
    Metzler S, Metzler V.Texas mushrooms: a field guide. 1st ed. Austin: University of Texas Press; 1992.Google Scholar
  3. 3.
    Ford MD. Clinical toxicology. Philadelphia: W. B. Saunders. 2001.Google Scholar
  4. 4.
    Gussow L. The optimal management of mushroom poisoning remains undetermined.West J Med 2000; 173(5): 317–318.PubMedCrossRefGoogle Scholar
  5. 5.
    Centers for Disease Control and Prevention. Amanita phalloides Mushroom Poisoning—Northern California, January 1997. MMWR Morb Mortal Wkly Rep 1997;46(22): 489–492.Google Scholar
  6. 6.
    Faulstich H. Mushroom poisoning.Lancet 1980;2(8198): 794–795.PubMedCrossRefGoogle Scholar
  7. 7.
    Weber T. Mushroom poisoning.Lancet 1980;2(8195 pt 1): 640.PubMedCrossRefGoogle Scholar
  8. 8.
    Bronstein AC, et al. 2006 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS).Clin Toxicol (Phila) 2007;45(8):815–917.Google Scholar

Copyright information

© American College of Medical Toxicology 2009

Authors and Affiliations

  • George A. Barbee
    • 1
    Email author
  • Cristóbal S. Berry-Cabán
    • 2
  • James D. Barry
    • 3
  • Douglas J. Borys
    • 4
  • John A. Ward
    • 3
  • Steven W. Salyer
    • 3
  1. 1.Department of Emergency MedicineWomack Army Medical CenterFort Bragg
  2. 2.Information Management Division, Clinical Data ServicesWomack Army Medical CenterFort Bragg
  3. 3.Brooke Army Medical CenterFort Sam Houston
  4. 4.Central Texas Poison CenterScott & White Memorial HospitalTemple

Personalised recommendations